Dr. Verbeck partners with InspectIR to develop commercial drug detecting breathalyzer | BioDiscovery Institute

COVID-19 updates—In an effort to keep everyone healthy, UNT's on-campus operations are closed until further notice. We're serving students remotely. Please stay connected. Stay up to date on UNT’s response to COVID-19 (Coronavirus).

September 14, 2018

Dr. Verbeck partners with InspectIR to develop commercial drug detecting breathalyzer

Dr. Verbeck and InspectIR are partnering to commercialize a system to detect drugs by analying a person's breath using a technoloy developed by Dr. Verbeck's. Read more about the story here!